Global Antimicrobial Peptides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Antimicrobial Peptides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

According to our (Global Info Research) latest study, the global Antimicrobial Peptides market size was valued at US$ 5.4 million in 2023 and is forecast to a readjusted size of USD 7.8 million by 2030 with a CAGR of 5.3% during review period.

The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.

By region, North America had the highest share of sales, at about 35%.

This report is a detailed and comprehensive analysis for global Antimicrobial Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Antimicrobial Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Mg), and average selling prices (US$/Mg), 2019-2030

Global Antimicrobial Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Mg), and average selling prices (US$/Mg), 2019-2030

Global Antimicrobial Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Mg), and average selling prices (US$/Mg), 2019-2030

Global Antimicrobial Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Mg), and ASP (US$/Mg), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Antimicrobial Peptides

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Antimicrobial Peptides market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech, Sunsmile, Ruixing Biotechnology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Antimicrobial Peptides market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides

Market segment by Application
Pharmaceuticals
Feed Additives
Others

Major players covered
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Antimicrobial Peptides product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Antimicrobial Peptides, with price, sales quantity, revenue, and global market share of Antimicrobial Peptides from 2019 to 2024.

Chapter 3, the Antimicrobial Peptides competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Antimicrobial Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Antimicrobial Peptides market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Antimicrobial Peptides.

Chapter 14 and 15, to describe Antimicrobial Peptides sales channel, distributors, customers, research findings and conclusion.